Acetaminophen Relieves Inflammatory Pain through CB1Cannabinoid Receptors in the Rostral Ventromedial Medulla
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Acetaminophen (paracetamol) is a widely used analgesic and antipyretic drug with only incompletely understood mechanisms of action. Previous work, using models of acute nociceptive pain, indicated that analgesia by acetaminophen involves an indirect activation of CB 1 receptors by the acetaminophen metabolite and endocannabinoid reuptake inhibitor AM 404. However, the contribution of the cannabinoid system to antihyperalgesia against inflammatory pain, the main indication of acetaminophen, and the precise site of the relevant CB 1 receptors have remained elusive. Here, we analyzed acetaminophen analgesia in mice of either sex with inflammatory pain and found that acetaminophen exerted a dose-dependent antihyperalgesic action, which was mimicked by intrathecally injected AM 404. Both compounds lost their antihyperalgesic activity in CB1−/−mice, confirming the involvement of the cannabinoid system. Consistent with a mechanism downstream of proinflammatory prostaglandin formation, acetaminophen also reversed hyperalgesia induced by intrathecal prostaglandin E 2. To distinguish between a peripheral/spinal and a supraspinal action, we administered acetaminophen and AM 404 to hoxB8-CB1−/−mice, which lack CB 1 receptors from the peripheral nervous system and the spinal cord. These mice exhibited unchanged antihyperalgesia indicating a supraspinal site of action. Accordingly, local injection of the CB 1 receptor antagonist rimonabant into the rostral ventromedial medulla blocked acetaminophen-induced antihyperalgesia, while local rostral ventromedial medulla injection of AM 404 reduced hyperalgesia in wild-type mice but not in CB1−/−mice. Our results indicate that the cannabinoid system contributes not only to acetaminophen analgesia against acute pain but also against inflammatory pain, and suggest that the relevant CB 1 receptors reside in the rostral ventromedial medulla. SIGNIFICANCE STATEMENT Acetaminophen is a widely used analgesic drug with multiple but only incompletely understood mechanisms of action, including a facilitation of endogenous cannabinoid signaling via one of its metabolites. Our present data indicate that enhanced cannabinoid signaling is also responsible for the analgesic effects of acetaminophen against inflammatory pain. Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB 1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“…in wild-type mice (C57BL/6J; www.jax. org/strain/000664), CB1 / mice (genetic background C57BL/6N; www. informatics.jax.org/allele/MGI:2182924) (Marsicano et al., 2002), and hoxb8-CB1 / mice (genetic background C57BL/6; http://www.informatics. jax.org/allele/MGI:4881836) (Witschi et al.,…”
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · cited 2×
“Because CB1 receptors are densely expressed on different types of intrinsic spinal dorsal horn neurons and on sensory fiber terminals (Tsou et al., 1998; Farquhar-Smith et al., 2000; Bridges et al., 2003; Hegyi et al., 2009; Nyilas et al., 2009), experiments first focused on a possible RVM AM 404”
BackgroundCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208 · cited 2×
“org/allele/MGI:3045419) (Marsicano et al., 2003) with mice expressing in addition the cre recombinase in spinal cord neurons and glial cells as well as in neurons of the DRGs (hoxb8-cre mice) (Witschi et al.”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 13×
“Distribution of CB1 receptor mRNA and protein in the RVM In many parts of the CNS, cannabinoid receptors are located on the presynaptic axon terminal where they control neuronal activity through the inhibition of neurotransmitter release.”
BackgroundResultInfluentialAn endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · cited 1×
“Our results are thus in line with the important role of supraspinal CB1 receptors in stress-induced analgesia (Hohmann et al., 2005; Suplita et al., 2006).”
ResultParacetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674 · cited 1×
“However, acetaminophen is largely devoid of anti-inflammatory activity (Clissold, 1986; Bertolini et al., 2006; Brunton et al., 2011), which is a hallmark effect of classical COX inhibitors.”
BackgroundMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571
To Scale or Not to Scale: The Principles of Dose Extrapolation
Sharma, V., & McNeill, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00267.x · Cited by 544 · cited 1×
“On the other hand, a 10- to 15-fold difference between effective doses in humans and rodents is not unusual given the much higher metabolic rate of mice (Sharma and McNeill, 2009).”
BackgroundAcetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Hinz, B., Cheremina, O., & Brune, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-8506com · Cited by 478 · cited 2×
“An ex vivo study performed in human volunteers demonstrated inhibition of COX-1 and COX-2 following the oral administration of acetaminophen (Hinz et al., 2008), and AM 404 has also been shown to block COX-1 and COX-2 in lipopolysaccharidestimulated macrophages (Högestätt et al., 2005).”
BackgroundAn analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · cited 1×
“…critical role of the RVM in antihyperalgesia by systemic acetaminophen The RVM serves well-established roles in endogenous pain control (Heinricher and Fields, 2013) and as a site of action of centrally acting analgesic drugs, including cannabinoid ligands (Meng et al., 1998; Suplita et al., 2005).”
BackgroundKozak, K. R., Rowlinson, S. W., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007088200 · Cited by 390 · cited 2×
“In this context, it is important to note that COX-2 contributes to the metabolism of endocannabinoids (Yu et al., 1997; Kozak et al., 2000).”
BackgroundDe Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02082-2 · Cited by 347
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279 · cited 7×
“However, neither the present nor previously published results (Ottani et al., 2006; Dani et al., 2007; Mallet et al., 2008) exclude an involvement of COX-1 or COX-2 (Flower and Vane, 1972; Hanel and Lands, 1982; Muth-Selbach et al.”
BackgroundResultInfluentialCannabinoid CB1 Receptor Expression in Rat Spinal Cord
Farquhar-Smith, W. P., Egertová, M., Bradbury, E. J., McMahon, S. B., Rice, A. S. C., & Elphick, M. R. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0844 · Cited by 268
Clissold, S. P. (1986) · Drugs · doi:10.2165/00003495-198600324-00005 · Cited by 244
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230 · cited 1×
“AM 404 increases tissue concentrations of the endocannabinoid arachidonoyl ethanolamide, also known as anandamide, through an inhibition of anandamide reuptake into neurons and astrocytes (Beltramo et al., 1997; Fegley et al., 2004).”
BackgroundEndocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., & Eschalier, A. (2008) · Pain · doi:10.1016/j.pain.2008.03.030 · Cited by 223 · cited 6×
“Our experiments with local injection of rimonabant and AM 404 into the RVM provide strong support for this scenario (see also Högestätt et al., 2005; Mallet et al., 2008, 2010; Dalmann et al., 2015).”
BackgroundMethodResultInfluentialBoutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209 · cited 4×
“In this context, it is important to note that COX-2 contributes to the metabolism of endocannabinoids (Yu et al., 1997; Kozak et al., 2000).”
BackgroundResultInfluentialSpinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Reinold, H., Ahmadi, S., Depner, U. B., Layh, B., Heindl, C., Hamza, M., Pahl, A., Brune, K., Narumiya, S., Müller, U., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23618 · Cited by 202 · cited 5×
“To test whether acetaminophen reduces inflammatory hyperalgesia through a mechanism downstream of central prostaglandin production, we induced hyperalgesia through intrathecal PGE2 injection (Taiwo and Levine, 1986; Uda et al., 1990; Reinold et al., 2005).”
BackgroundMethodInfluentialSelf-citationTRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception
Mallet, C., Barrière, D. A., Ermund, A., Jönsson, B. A. G., Eschalier, A., Zygmunt, P. M., & Högestätt, E. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012748 · Cited by 165 · cited 8×
“Our experiments with local injection of rimonabant and AM 404 into the RVM provide strong support for this scenario (see also Högestätt et al., 2005; Mallet et al., 2008, 2010; Dalmann et al., 2015).”
BackgroundMethodResultInfluentialAntinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems
Tjølsen, A., Lund, A., & Hole, K. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90036-p · Cited by 163 · cited 5×
“…(COXs) (Flower and Vane, 1972; Hanel and Lands, 1982; Graham and Scott, 2005), the activation of spinal serotonergic descending projections (Tjølsen et al., 1991; Pini et al., 1996), an involvement of the brain opioid system (Tjølsen et al., 1991; Herrero and Headley, 1996; Pini et al.,…”
BackgroundInfluentialAcetaminophen Inhibits Spinal Prostaglandin E2Release after Peripheral Noxious Stimulation
Muth-Selbach, U. S., Tegeder, I., Brune, K., & Geisslinger, G. (1999) · Anesthesiology · doi:10.1097/00000542-199907000-00032 · Cited by 142 · cited 1×
“However, neither the present nor previously published results (Ottani et al., 2006; Dani et al., 2007; Mallet et al., 2008) exclude an involvement of COX-1 or COX-2 (Flower and Vane, 1972; Hanel and Lands, 1982; Muth-Selbach et al., 1999; Boutaud et al., 2002; Graham and Scott, 2005).”
ResultDani, M., Guindon, J., Lambert, C., & Beaulieu, P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.012 · Cited by 115
La Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R. A., Cuomo, V., Iacono, A., Raso, G. M., Meli, R., Piomelli, D., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100792 · Cited by 97 · cited 1×
“After spinal or systemic application, AM 404 exerts analgesic activity against acute pain, evoked by noxious chemical stimuli, as well as against inflammatory and neuropathic pain (Gühring et al., 2002; La Rana et al., 2006).”
BackgroundModification of anti-inflammatory drug effectiveness by ambient lipid peroxides
Hanel, A. M., & Lands, W. E. M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90565-2 · Cited by 95 · cited 13×
“Distribution of CB1 receptor mRNA and protein in the RVM In many parts of the CNS, cannabinoid receptors are located on the presynaptic axon terminal where they control neuronal activity through the inhibition of neurotransmitter release.”
BackgroundResultInfluentialTRPA1 mediates the hypothermic action of acetaminophen
Gentry, C., Andersson, D. A., & Bevan, S. (2015) · Scientific Reports · doi:10.1038/srep12771 · Cited by 50 · cited 6×
“, 2005) and the activation of TRPA1 via the acetaminophen metabolite NAPQI (Gentry et al., 2015).”
BackgroundMethodInfluentialLiang, Y., Huang, C., Hsu, K., & Takahashi, T. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.056986 · Cited by 42
Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context
Dalmann, R., Daulhac, L., Antri, M., Eschalier, A., & Mallet, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.006 · Cited by 32 · cited 4×
“…CB1 receptor agonists exert most of their analgesic action through CB1 receptors on peripheral nociceptors (Agarwal et al., 2007), our experiments in hoxB8-CB1 / , which lack CB1 receptors also from these cells, suggest that this is not the case for acetaminophen (see also Dalmann et al., 2015).”
BackgroundMethodResultInfluentialSandrini, M., Romualdi, P., Vitale, G., Morelli, G., Capobianco, A., Pini, L. A., & Candeletti, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00623-2 · Cited by 18 · cited 2×
“, 1996), an involvement of the brain opioid system (Tjølsen et al., 1991; Herrero and Headley, 1996; Pini et al., 1996; Sandrini et al., 2001), inhibition of nitric oxide generation (Björkman et al.”
Background
Cited by
Paracetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
Rivers-Auty, J., Mather, A. E., Peters, R., Lawrence, C. B., & Brough, D. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa109 · Cited by 130
Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey
Barrière, D. A., Boumezbeur, F., Dalmann, R., Cadeddu, R., Richard, D., Pinguet, J., Daulhac, L., Sarret, P., Whittingstall, K., Keller, M., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14934 · Cited by 34
Metadata
- Authors
- Klinger-Gratz, P. P., Ralvenius, W. T., Neumann, E., Kato, A., Nyilas, R., Lele, Z., Katona, I., & Zeilhofer, H. U.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2017-11-22
- Volume
- 38
- Issue
- 2
- Pages
- 322-334
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2769469764
- Cited by
- 74
- References
- 30
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.